Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 8, 2026 | CMS / Medicare | Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea | Metadata changed |
| May 8, 2026 | CMS / Medicare | Peripheral Nerve Blocks and Procedures for Chronic Pain | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Off-label Use of Rituximab and Rituximab Biosimilars | Metadata changed |
| May 8, 2026 | CMS / Medicare | Skilled Therapy Services in the SNF PPS Setting | Metadata changed |
| May 8, 2026 | CMS / Medicare | Frequency of Hemodialysis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: MDS FISH | Metadata changed |
| May 8, 2026 | CMS / Medicare | Ultrasound Diagnostic Procedures | Metadata changed |
| May 8, 2026 | CMS / Medicare | Laparoscopic Sleeve Gastrectomy for Severe Obesity | Metadata changed |
| May 8, 2026 | CMS / Medicare | Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Treatment of Varicose Veins of Lower Extremities | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Metadata changed |
| May 8, 2026 | CMS / Medicare | Corset Used as Hernia Support | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Off-label Use of Rituximab and Rituximab Biosimilars | Metadata changed |
| May 8, 2026 | CMS / Medicare | Commodes - Policy Article | Metadata changed |
| May 8, 2026 | CMS / Medicare | Implantable Continuous Glucose Monitors (I-CGM) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Billing and Coding: Fracture Care | Metadata changed |
| May 8, 2026 | CMS / Medicare | Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Breast Cancer Index (BCI) Gene Expression Test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Intraoperative Neurophysiological Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | In Vitro Chemosensitivity & Chemoresistance Assays | Metadata changed |
| May 8, 2026 | CMS / Medicare | Digital Subtraction Angiography | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: EndoPredict Breast Cancer Gene Expression Test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Biomarker Testing for Prostate Cancer Diagnosis | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Defining panel services in MolDX | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: NRAS Genetic Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Metadata changed |
| May 8, 2026 | CMS / Medicare | Treatment of Males with Low Testosterone | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Genetic Testing in Oncology: Specific Tests | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Cognitive Assessment and Care Plan Service | Metadata changed |
| May 8, 2026 | CMS / Medicare | Debridement of Mycotic Nails | Metadata changed |
| May 8, 2026 | CMS / Medicare | Outpatient Observation Bed/Room Services | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 8, 2026 | CMS / Medicare | Implantable Continuous Glucose Monitors (I-CGM) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Transcendental Meditation | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Allergy Testing (L36402) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test (DL37919) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Vagus Nerve Stimulation (VNS) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Vestibular Function Tests | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Voretigene Neparvovec-rzyl (Luxturnaâ¢) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Lower Esophageal Magnetic Sphincter Augmentation | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Metadata changed |
| May 8, 2026 | CMS / Medicare | CT of the Abdomen and Pelvis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Multimarker Serum Tests Related to Ovarian Cancer Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Treatment of Males with Low Testosterone | Metadata changed |